Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1

  • Authors:
    • Kebin Zheng
    • Guangyi Wang
    • Chunhui Li
    • Xiaosong Shan
    • Haipeng Liu
  • View Affiliations

  • Published online on: May 15, 2015     https://doi.org/10.3892/or.2015.3983
  • Pages: 272-278
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Integrin-linked kinase (ILK) is a highly conserved serine-threonine protein kinase that interacts with cytoplasmic domains of integrin subunits in tumor tissues. However, the relationship between gliomas and ILK is elusive. The present study aimed to investigate the role of ILK in a human glioma cell line (U251). ILK stable expressing vector, U251ILK-PGFP-V-RS-shRNA, was established and named as U251-si. The empty-PGFP-V-RS-shRNA (U251-N) was employed as the control. Quantitative real-time PCR and western blot analysis were used to detect ILK and E-cadherin mRNA and protein expression, respectively. Cell cycle analysis was employed to examine the cell cycle distribution. Cell migration was detected using a wound healing assay, and cell invasion was detected using a Transwell invasion assay. Tumor size and weight were also examined. The results indicated that ILK was expressed at a lower level at both the mRNA and protein levels in the U251-si group compared with the U251-N group (p<0.01). ILK knockdown suppressed cell proliferation of the glioma cells. Knockdown of ILK reduced the migratory and invasive potentials of the glioma cells. Inhibition of ILK expression upregulated E-cadherin and downregulated cyclin D1 in the glioma cells compared to the U251-N group (p<0.05). Knockdown of ILK in the U251 cells attenuated the ability of U251 cells to form tumors in nude mice and impaired glioma cell in vivo tumorigenicity. In conclusion, knockdown of ILK inhibits glioma cell migration, invasion and proliferation through upregulation of E-cadherin and downregulation of cyclin D1. Our results suggest that ILK may serve as a promising therapeutic target for glioma.
View Figures
View References

Related Articles

Journal Cover

July-2015
Volume 34 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zheng K, Wang G, Li C, Shan X and Liu H: Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1. Oncol Rep 34: 272-278, 2015
APA
Zheng, K., Wang, G., Li, C., Shan, X., & Liu, H. (2015). Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1. Oncology Reports, 34, 272-278. https://doi.org/10.3892/or.2015.3983
MLA
Zheng, K., Wang, G., Li, C., Shan, X., Liu, H."Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1". Oncology Reports 34.1 (2015): 272-278.
Chicago
Zheng, K., Wang, G., Li, C., Shan, X., Liu, H."Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1". Oncology Reports 34, no. 1 (2015): 272-278. https://doi.org/10.3892/or.2015.3983